Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 32Pain, Postoperative 5Depression 3Anxiety Disorders 3Neoplasm Metastasis 2Fatigue 2Triple Negative Breast Neoplasms 1Sleep Initiation and Maintenance Disorders 1Skin Abnormalities 1Peripheral Nervous System Diseases 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Mastodynia 1Intranasal Dexmedetomidine Breast Cancer Local Anaesthesia 1Chronic Pain 1Chemotherapy-Related Cognitive Impairment 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasm Malignant Primary 1Breast Cancer Female 1Agnosia 1

Interventions

Cognitive Behavioral Therapy 6Acupuncture Therapy 3Electroacupuncture 2Control Groups 2Breathing Exercises 2suvorexant 1cyclobenzaprine 1Water 1Therapeutics 1Saline Solution 1Respiration 1Rehabilitation 1Physical Therapy Modalities 1Patient Portals 1Modafinil 1Mindfulness-Based Stress Reduction 1Massage 1Exercise Movement Techniques 1Esketamine 1Dexmedetomidine 1Acupuncture, Ear 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sleep Initiation and Maintenance Disorders × Saline Solution × Breast × Clear all
NCT05732064 2025-07-31

Dexmedetomidine-esketamine Combined Nasal Administration and Perioperative Sleep Quality

Peking University First Hospital

Phase 4 Completed
180 enrolled
Breast

Breast Neoplasms, Sleep Initiation and Maintenance Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡